It has been demonstrated that pathogenic germline variants in the CBL gene impact the ubiquitylation and migration of EGFR, resulting in loss of downregulation function of the CBL protein in the RAS-MAPK pathway, which leads to Noonan syndrome and other RASopathies (65). This evidence concerns the gene CBL and Noonan syndrome.